Bowel habits written in the DNA: new clues for irritable bowel syndrome

by CIC bioGUNE

3 years ago
Ikerbasque, BRTA, CIC bioGUNE, irritable bowel

In a large-scale study published in Cell Genomics, researchers studied the DNA of more than 160,000 people who provided information on the frequency of their bowel movements. Genetic profiles and...

Jóvenes investigadores e investigadoras reciben formación para desarrollar vacunas innovadoras antibacterianas

by CIC bioGUNE

3 years ago
BRTA, CIC bioGUNE, BactiVax, bacterial infections, vaccines

CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), is hosting until Thursday, 25 November, the congress of the BactiVax Project, a European training network funded by the Europ...

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

by CIC bioGUNE

3 years ago
Ikerbasque, CIC bioGUNE, BRTA, irritable bowel syndrome, mental health disorders

The study, co-led by researchers from CIC bioGUNE, has analysed genetic data from over 50,000 patients. The research highlights the close relationship between brain and gut health and paves the way f...

Genetic defects and carbohydrate malabsorption lurking behind irritable bowel syndrome

by CIC bioGUNE

3 years ago
CIC bioGUNE, Ikerbasque, genetic defects, carbohydrates, digestion, BRTA

A new study, led by researchers at CIC bioGUNE, suggests genetic defects in carbohydrates digestion may be (mis)diagnosed as IBS in some patients.

CIC bioGUNE, ONCE Foundation and Ikerbasque sign an agreement to promote the research career of people with disabilities in the field of health sciences

by CIC bioGUNE

4 years ago
CIC bioGUNE, research, Ikerbasque, BRTA, ONCE Foundation, people with disabilitie

The successful candidates will conduct their research at CIC bioGUNE. The aim of the collaboration agreement is to improve equal opportunity, universal accessibility, inclusion and non-discrimination...

CIC bioGUNE researchers describe a new microRNA determinant of response to sorafenib in patients with hepatocellular carcinoma

by CIC bioGUNE

4 years ago
sorafenib, hepatocellular carcinoma, cancer, CIBEREHD, BRTA, CIC bioGUNE

Researchers from the Liver Disease Laboratory at CIC bioGUNE, a member of the Basque Research & Technology Alliance (BRTA), have described a new microRNA, a gene expression regulator molecule, which d...

Inhibition of a mitochondrial protein, a new therapeutic target for cholestatic liver diseases

by CIC bioGUNE

4 years ago
mitochondria, BRTA, CIBEREHD, IDIVAL, CIC bioGUNE, liver diseases

The presence of this protein slows down the activity of the mitochondria, decreasing their ability to eliminate toxic substances such as certain bile acids.

Open Innovation Test Bed to validate and up-scale new materials for tribological applications

by IK4-TEKNIKER

4 years ago
BRTA, i-TRIBOMAT, tribological, industrial sector, surfaces

Tekniker participates in the European project i-TRIBOMAT with the aim of developing the world’s first Open Innovation Test Bed dedicated to validating and up-scaling new materials in tribological ap...

CIC bioGUNE researchers decipher the molecular mechanism of a key enzyme in gut microbiota

by CIC bioGUNE

5 years ago
molecula, enzyme, microbiota, BRTA

The findings, published in the journal Nature Communications, will contribute to the development and design of enzymes exhibiting characteristics of biotechnological interest. The composition and phy...